Literature DB >> 27291328

Autoimmune diabetes superimposed on type 2 diabetes in a patient initiated on immunotherapy for lung cancer.

M Alhusseini1, J Samantray2.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27291328     DOI： 10.1016/j.diabet.2016.05.007

Source DB:  PubMed          Journal:  Diabetes Metab        ISSN： 1262-3636            Impact factor:   6.041


× No keyword cloud information.
  8 in total

1.  Diabetes mellitus secondary to treatment with immune checkpoint inhibitors.

Authors:  V Venetsanaki; A Boutis; A Chrisoulidou; P Papakotoulas
Journal:  Curr Oncol       Date:  2019-02-01       Impact factor: 3.677

Review 2.  Is immune checkpoint inhibitor-associated diabetes the same as fulminant type 1 diabetes mellitus?

Authors:  Angelos Kyriacou; Eka Melson; Wentin Chen; Punith Kempegowda
Journal:  Clin Med (Lond)       Date:  2020-07       Impact factor: 2.659

Review 3.  Endocrine Toxicity of Cancer Immunotherapy Targeting Immune Checkpoints.

Authors:  Lee-Shing Chang; Romualdo Barroso-Sousa; Sara M Tolaney; F Stephen Hodi; Ursula B Kaiser; Le Min
Journal:  Endocr Rev       Date:  2019-02-01       Impact factor: 19.871

Review 4.  Spectrum of immune checkpoint inhibitors-induced endocrinopathies in cancer patients: a scoping review of case reports.

Authors:  Meng H Tan; Ravi Iyengar; Kara Mizokami-Stout; Sarah Yentz; Mark P MacEachern; Li Yan Shen; Bruce Redman; Roma Gianchandani
Journal:  Clin Diabetes Endocrinol       Date:  2019-01-22

5.  Immune Checkpoint Blockade Anti-PD-L1 as a Trigger for Autoimmune Polyendocrine Syndrome.

Authors:  Giulia Lanzolla; Alberto Coppelli; Mirco Cosottini; Stefano Del Prato; Claudio Marcocci; Isabella Lupi
Journal:  J Endocr Soc       Date:  2019-01-08

6.  Immune checkpoint inhibitors and type 1 diabetes mellitus: a case report and systematic review.

Authors:  Jeroen M K de Filette; Joeri J Pen; Lore Decoster; Thomas Vissers; Bert Bravenboer; Bart J Van der Auwera; Frans K Gorus; Bart O Roep; Sandrine Aspeslagh; Bart Neyns; Brigitte Velkeniers; Aan V Kharagjitsingh
Journal:  Eur J Endocrinol       Date:  2019-09       Impact factor: 6.664

Review 7.  Anti-programmed cell death protein 1 (anti-PD1) immunotherapy induced autoimmune polyendocrine syndrome type II (APS-2): a case report and review of the literature.

Authors:  Ashray Gunjur; Oliver Klein; Damien Kee; Jonathan Cebon
Journal:  J Immunother Cancer       Date:  2019-09-05       Impact factor: 13.751

Review 8.  Sintilimab induced diabetic ketoacidosis in a patient with small cell lung cancer: A case report and literature review.

Authors:  Xiaofei Huang; Mei Yang; Liu Wang; Libo Li; Xiaowei Zhong
Journal:  Medicine (Baltimore)       Date:  2021-05-14       Impact factor: 1.889
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.